Related Experiment Video

Updated: Mar 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

1.0K

Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive

Rohit R Bhosale1, H V Gangadharappa2, Umme Hani3

  • 1Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara Nagar, Mysuru- 570015, Karnataka. India.

Current Drug Targets
|June 15, 2016
PubMed
Abstract

Insights

Novel drug delivery systems and therapies show promise for managing prostate cancer (PC). These advanced approaches enhance targeted delivery, improving treatment effectiveness and potentially leading to new ways to eliminate PC.

Area of Science:

  • Oncology
  • Nanomedicine
  • Drug Delivery Systems

Background:

  • Prostate cancer (PC) is a leading cause of cancer deaths in men, with targeted drug delivery being a major challenge.
  • Current treatments struggle with effective delivery of therapeutic agents like proteins, peptides, and nucleic acids to prostate cancer cells.
  • There is a critical need for advanced systems and strategies to improve the efficacy of prostate cancer therapies.

Purpose of the Study:

  • To review and report recent research findings on novel drug delivery systems and therapeutic approaches for prostate cancer management.
  • To consolidate information on diverse and emerging strategies for treating PC.
  • To provide an overview of current advancements in PC treatment modalities.

Main Methods:

  • Review of existing literature on novel drug delivery systems for prostate cancer.
  • Analysis of various therapeutic strategies including nanoparticles, liposomes, radiation, hormonal, gene, and immunologic therapies.
  • Synthesis of findings on targeted drug delivery and release mechanisms in the prostate cancer microenvironment.

Main Results:

  • Novel drug delivery systems such as nanoparticles and liposomes are being developed to enhance chemotherapeutic agent delivery.
  • Therapeutic strategies including radiation, hormonal, gene, and immunologic therapies are being investigated for PC management.
  • These advanced systems and therapies aim to improve drug accumulation and release specifically within prostate cancer cells.

Conclusions:

  • The reviewed novel drug delivery systems and therapies demonstrate precision, safety, and effectiveness.
  • These advancements offer a promising new direction for the eradication of prostate cancer.
  • Further research into these targeted approaches could significantly improve patient outcomes.
Keywords:
Prostate cancerbrachytherapydelivery systemsdrug targetsgene therapyorchiectomy

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
179
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
83
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
183
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
201
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
165